Nanoarchitectonics of Doxycycline-Loaded Vitamin E–D-α-Tocopheryl Polyethylene Glycol 1000 Succinate Micelles for Ovarian Cancer Stem Cell Treatment

References

• Keyvani V , FarshchianM, EsmaeiliS-Aet al. Ovarian cancer stem cells and targeted therapy. J. Ovarian Res.12(1), 120 (2019).
   PubMed Web of Science ®Google Scholar
• Yang W , KimD, KimDK, ChoiKU, SuhDS, KimJH. Therapeutic strategies for targeting ovarian cancer stem cells. Int. J. Mol. Sci.22(10), 5059 (2021).
   PubMed Web of Science ®Google Scholar
• Stewart C , RalyeaC, LockwoodS. Ovarian cancer: an integrated review. Semin. Oncol. Nurs.35(2), 151–156 (2019).
   PubMed Web of Science ®Google Scholar
• Terraneo N , JacobF, DubrovskaA, GrünbergJ. Novel therapeutic strategies for ovarian cancer stem cells. Front. Oncol.10 (2020).
   PubMedGoogle Scholar
• Torre LA , TrabertB, DesantisCEet al. Ovarian cancer statistics, 2018. CA Cancer J. Clin.68(4), 284–296 (2018).
   PubMed Web of Science ®Google Scholar
• Pieterse Z , Amaya-PadillaMA, SingomatTet al. Ovarian cancer stem cells and their role in drug resistance. Int. J. Biochem. Cell Biol.106, 117–126 (2019).
   PubMed Web of Science ®Google Scholar
• Jin X , JinX, KimH. Cancer stem cells and differentiation therapy. Tumour Biol.39(10), 1010428317729933 (2017).
   Google Scholar
• Yang L , ShiP, ZhaoGet al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Ther.5(1), 8 (2020).
   PubMed Web of Science ®Google Scholar
• Garcia-Mayea Y , MirC, MassonF, PaciucciR, MeLL. Insights into new mechanisms and models of cancer stem cell multidrug resistance. Semin. Cancer Biol.60, 166–180 (2020).
   PubMed Web of Science ®Google Scholar
• Lamb R , FiorilloM, ChadwickAet al. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: implications for more effective radiation therapy. Oncotarget6(16), 14005–14025 (2015).
   PubMed Web of Science ®Google Scholar
• Fiorillo M , TóthF, SotgiaF, LisantiMP. Doxycycline, azithromycin and vitamin C (DAV): a potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs). Aging (Albany NY)11(8), 2202–2216 (2019).
   PubMedGoogle Scholar
• De Francesco EM , MaggioliniM, TanowitzHB, SotgiaF, LisantiMP. Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for optimizing anti-angiogenic therapy. Oncotarget8(34), 56126–56142 (2017).
   PubMedGoogle Scholar
• Bartakova A , MichalovaK, PreslJ, VlasakP, KostunJ, BoudaJ. CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma. J. Obstet. Gynaecol.38(1), 110–114 (2018).
   PubMedGoogle Scholar
• Lin J , DingD. The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis. Cancer Cell Int.17, 8 (2017).
   PubMed Web of Science ®Google Scholar
• Thapa R , WilsonGD. The importance of CD44 as a stem cell biomarker and therapeutic target in cancer. Stem Cells Int.2016, 2087204 (2016).
   PubMed Web of Science ®Google Scholar
• Al-Alem LF , PandyaUM, BakerATet al. Ovarian cancer stem cells: what progress have we made? Int. J. Biochem. Cell Biol. 107, 92–103 (2019).
   PubMed Web of Science ®Google Scholar
• Andrade F , RafaelD, Vilar-HernándezMet al. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. J. Control. Rel.331, 198–212 (2021).
   PubMed Web of Science ®Google Scholar
• Yadav D , DewanganHK. PEGYLATION: an important approach for novel drug delivery system. J. Biomater. Sci. Polym. Ed.32(2), 266–280 (2021).
   PubMed Web of Science ®Google Scholar
• Kumbhar PS , NadafS, ManjappaASet al. D-α-tocopheryl polyethylene glycol succinate: a review of multifarious applications in nanomedicines. OpenNano6, 100036 (2022).
   Google Scholar
• Tavares Luiz M , DelelloDi Filippo L, CarolinaAlves Ret al. The use of TPGS in drug delivery systems to overcome biological barriers. Eur. Polym. J.142, 110129 (2021).
   Web of Science ®Google Scholar
• Bernabeu E , GonzalezL, CagelM, GergicEP, MorettonMA, ChiappettaDA. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf. B Biointerfaces140, 403–411 (2016).
   PubMed Web of Science ®Google Scholar
• Muthu MS , KulkarniSA, LiuY, FengSS. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond.)7(3), 353–364 (2012).
   PubMed Web of Science ®Google Scholar
• Tyrrell ZL , ShenY, RadoszM. Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog. Polym. Sci.35(9), 1128–1143 (2010).
   Web of Science ®Google Scholar
• Akrami M , BalalaieS, HosseinkhaniSet al. Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms. Sci. Rep.6(1), 31030 (2016).
   PubMedGoogle Scholar
• Lu Y , MaW, MaoJet al. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling. Chem. Biol. Interact.228, 100–107 (2015).
   PubMed Web of Science ®Google Scholar
• Lamb R , OzsvariB, LisantiCLet al. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease. Oncotarget6(7), 4569–4584 (2015).
   PubMed Web of Science ®Google Scholar
• Hoshyar N , GrayS, HanH, BaoG. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine11(6), 673–692 (2016).
   PubMed Web of Science ®Google Scholar
• Danaei M , DehghankholdM, AtaeiSet al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics10(2), 57 (2018).
   PubMed Web of Science ®Google Scholar
• Mahajan HS , PatilPH. Central composite design-based optimization of lopinavir vitamin E-TPGS micelle: in vitro characterization and in vivo pharmacokinetic study. Colloids Surf. B Biointerfaces194, 111149 (2020).
   PubMed Web of Science ®Google Scholar
• Wang S , LiuR, FuY, KaoWJ. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin. Drug Deliv.17(9), 1289–1304 (2020).
   PubMed Web of Science ®Google Scholar
• Scatena C , RoncellaM, DiPaolo Aet al. Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study. Front. Oncol.8, 452 (2018).
   PubMed Web of Science ®Google Scholar
• Rajendran V , JainMV. In vitro tumorigenic assay: colony forming assay for cancer stem cells. In: Cancer Stem Cells: Methods and Protocols.PapaccioG, DesiderioV ( Eds). Springer New York, NY, USA, 89–95 (2018).
   Google Scholar